Oramed Pharmaceuticals
ORMP
#8979
Rank
โ‚น12.29 B
Marketcap
โ‚น308.47
Share price
0.29%
Change (1 day)
61.66%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): โ‚น74.01

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น73.06. In 2024 the company made an earnings per share (EPS) of -โ‚น43.29 a decrease over its 2023 EPS that were of โ‚น12.63.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น74.01-270.94%
2024-โ‚น43.29-442.86%
2023โ‚น12.63-114.89%
2022-โ‚น84.7820.51%
2021-โ‚น70.3539.29%
2020-โ‚น50.51-31.71%
2019-โ‚น73.96-4.65%
2018-โ‚น77.578.86%
2017-โ‚น71.25-9.2%
2016-โ‚น78.4729.85%
2015-โ‚น60.438.06%
2014-โ‚น55.925.08%
2013-โ‚น53.223.51%
2012-โ‚น51.41137.5%
2011-โ‚น21.65-60%
2010-โ‚น54.12-0%
2009-โ‚น54.12-16.67%
2008-โ‚น64.94-25%
2007-โ‚น86.59700%
2006-โ‚น10.82303.56%
2005-โ‚น2.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
โ‚น316.89 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น334.23 357.49%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น535.76-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น17.14-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น27.06-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel